NBIX vs ROOT · P/E 45, rev $2.36B vs P/E 14, rev $1.18B
Neurocrine Biosciences Inc (NBIX) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the NBIX and ROOT stock pages for the full models.
Not investment advice.